Dr John J Croke, MD | |
725 Albany St, Shapiro 8, Boston, MA 02118-2526 | |
(617) 638-7420 | |
(617) 638-7289 |
Full Name | Dr John J Croke |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 38 Years |
Location | 725 Albany St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013994649 | NPI | - | NPPES |
110056889A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 59427 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Signature Healthcare Brockton Hospital | Brockton, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
South Shore Dermatology Physicians Pc | 4789767104 | 11 |
News Archive
Round About Place reported that Fidel Castro, undisputed dictator of Cuba has come out on state-run media and made some comments about the health care overhaul in the U.S. under the Obama administration. The remarks are shocking democrats and justifying the claims of conservatives concerning the bill that was signed into law on Tuesday by president Obama.
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
MAP Pharmaceuticals, Inc. today announced that it has completed a planned interim safety review of the open-label, long-term safety extension of the company's Phase 3 FREEDOM 301 clinical trial with its LEVADEX(TM) orally inhaled migraine therapy.
Various types of carbon-based nanomaterials, such as buckyballs and nanotubes, have shown promise as drug delivery tools and imaging agents, but reports of toxicity associated with some of these materials have raised questions about their ultimate utility in clinical oncology.
› Verified 3 days ago
Entity Name | South Shore Dermatology Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992988703 PECOS PAC ID: 4789767104 Enrollment ID: O20080208000161 |
News Archive
Round About Place reported that Fidel Castro, undisputed dictator of Cuba has come out on state-run media and made some comments about the health care overhaul in the U.S. under the Obama administration. The remarks are shocking democrats and justifying the claims of conservatives concerning the bill that was signed into law on Tuesday by president Obama.
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
MAP Pharmaceuticals, Inc. today announced that it has completed a planned interim safety review of the open-label, long-term safety extension of the company's Phase 3 FREEDOM 301 clinical trial with its LEVADEX(TM) orally inhaled migraine therapy.
Various types of carbon-based nanomaterials, such as buckyballs and nanotubes, have shown promise as drug delivery tools and imaging agents, but reports of toxicity associated with some of these materials have raised questions about their ultimate utility in clinical oncology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John J Croke, MD 720 Harrison Ave, Dob 503, Boston, MA 02118-2371 Ph: () - | Dr John J Croke, MD 725 Albany St, Shapiro 8, Boston, MA 02118-2526 Ph: (617) 638-7420 |
News Archive
Round About Place reported that Fidel Castro, undisputed dictator of Cuba has come out on state-run media and made some comments about the health care overhaul in the U.S. under the Obama administration. The remarks are shocking democrats and justifying the claims of conservatives concerning the bill that was signed into law on Tuesday by president Obama.
Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor's TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.
MAP Pharmaceuticals, Inc. today announced that it has completed a planned interim safety review of the open-label, long-term safety extension of the company's Phase 3 FREEDOM 301 clinical trial with its LEVADEX(TM) orally inhaled migraine therapy.
Various types of carbon-based nanomaterials, such as buckyballs and nanotubes, have shown promise as drug delivery tools and imaging agents, but reports of toxicity associated with some of these materials have raised questions about their ultimate utility in clinical oncology.
› Verified 3 days ago
Erica Dommasch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Shapiro 2, Boston, MA 02215 Phone: 617-667-3753 | |
Dr. Chantal Louise Cotter, MB BCH BAO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
Dr. Debjani Sahni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Joseph C Kvedar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Staniford St, Suite 200, Boston, MA 02114 Phone: 617-726-2914 Fax: 617-724-2135 | |
Ryan Char Kelm, Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St # 250, Boston, MA 02114 Phone: 617-724-6960 | |
Dr. David Attar Hashemi, MD, MBA Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St, Boston, MA 02114 Phone: 617-726-2914 |